Inventor · disambiguated record
Michael Brennan Wallace
Also filed as: WALLACE MICHAEL · WALLACE MICHAEL B · WALLACE MICHAEL BRENNAN
73 granted patents·10 pending applications·1,057 citations·filing 2000–2024
99Inventor score
Files withCELGENE QUANTICEL RES INC47QUANTICEL PHARMACEUTICALS INC13AGOURON PHARMA11MAYO FOUND MEDICAL EDUCATION & RES3MITAS MICHAEL2
Top patents by PatentIndex Score
83 records- 0198US9242968B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jan 26, 2016·17 cites·28 claims
- 0298US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0398US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0497US9447045B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·20 cites·16 claims
- 0597US7232912B2Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2005·Granted Jun 19, 2007·94 cites·2 claims
- 0697US6919461B2Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2002·Granted Jul 19, 2005·103 cites·8 claims
- 0797US6555539B2Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferationAGOURON PHARMA·Filed 2001·Granted Apr 29, 2003·171 cites·26 claims
- 0896US8952151B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2013·Granted Feb 10, 2015·21 cites·18 claims
- 0995US9643965B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·6 cites·5 claims
- 1094US11535616B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 27, 2022·2 cites·13 claims
- 1193US10112940B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 30, 2018·4 cites·6 claims
- 1293US9586902B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Mar 7, 2017·5 cites·30 claims
- 1393US9085534B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Jul 21, 2015·8 cites·34 claims
- 1492US10815234B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 27, 2020·2 cites·9 claims
- 1592US10208039B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 19, 2019·4 cites·8 claims
- 1692US10202381B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 12, 2019·4 cites·24 claims
- 1792US9815828B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Nov 14, 2017·4 cites·36 claims
- 1892US9107916B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 18, 2015·4 cites·38 claims
- 1991US10059687B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Aug 28, 2018·4 cites·17 claims
- 2091US10030017B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Jul 24, 2018·4 cites·4 claims
- 2191US9447046B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 20, 2016·4 cites·26 claims
- 2291US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 2390US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 2490US2025066355A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2024·Application pending·0 cites
- 2589US11020380B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jun 1, 2021·2 cites·27 claims
- 2689US10611763B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 7, 2020·2 cites·7 claims
- 2788US11890275B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2021·Granted Feb 6, 2024·1 cites·44 claims
- 2888US11214542B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jan 4, 2022·1 cites·17 claims
- 2987US2023286917A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2023·Application pending·0 cites
- 3086US10807956B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 20, 2020·1 cites·18 claims
- 3185US12172998B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2022·Granted Dec 24, 2024·0 cites·13 claims
- 3285US10870634B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 22, 2020·1 cites·11 claims
- 3385US10617680B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 14, 2020·3 cites·48 claims
- 3485US9873697B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 23, 2018·3 cites·20 claims
- 3585US9725441B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 8, 2017·2 cites·20 claims
- 3685US6462069B2Compounds, pharmaceutical compositions, and methods for inhibiting protein kinasesAGOURON PHARMA·Filed 2001·Granted Oct 8, 2002·21 cites·12 claims
- 3784US11001568B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted May 11, 2021·1 cites·14 claims
- 3884US9758517B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·2 cites·34 claims
- 3983US10654830B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·1 cites·5 claims
- 4083US10597365B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Mar 24, 2020·1 cites·14 claims
- 4183US10106534B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Oct 23, 2018·1 cites·25 claims
- 4283US9994561B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jun 12, 2018·1 cites·35 claims
- 4382US10179769B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 15, 2019·1 cites·14 claims
- 4482US9828343B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Nov 28, 2017·1 cites·12 claims
- 4581US10597379B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Mar 24, 2020·1 cites·4 claims
- 4681US10413346B2Surgical cutting deviceMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Sep 17, 2019·4 cites·12 claims
- 4781US9738637B2Histone demethylase inhibitorsQUANTICEL PHARMACEUTICALS INC·Filed 2014·Granted Aug 22, 2017·3 cites·8 claims
- 4881US2024293381A1Therapeutic CompoundsCELGENE QUANTICEL RES INC·Filed 2024·Application pending·0 cites
- 4980US9611221B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Apr 4, 2017·1 cites·27 claims
- 5078US6720346B2Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferationAGOURON PHARMA·Filed 2002·Granted Apr 13, 2004·14 cites·30 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Brennan Wallace files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →